Chamindi Seneviratne

Chamindi Seneviratne, MD is an Adjunct Assistant Professor in Pharmacology at the University of Maryland School of Medicine, conducting research at the Health Sciences Facility III in Baltimore, MD. Her work focuses on addiction genomics, pharmacogenetics, and biomarker discovery for alcohol and substance use disorders. She has led multiple clinical trials including phase-1 studies and pharmacogenetic analyses.

• Education: MD from Riga Stradins University (Latvia), postgraduate training at University of Texas Health Science Center and University of Virginia
• Research Focus: Explores genetic interactions in addiction, placebo mechanisms, and transcriptomic responses to substance use
• Clinical Expertise: Conducts pharmacogenetic studies on treatments like ondansetron and topiramate for alcohol use disorder
• Methodologies: Utilizes single-cell transcriptomics, biomarker validation, and clinical trial designs

Her publications reveal a consistent focus on genetic biomarkers for addiction treatment outcomes, neuroimmune interactions in substance misuse, and placebo effect modulation in clinical populations. Current work includes cutting-edge research on sex-specific signatures in alcohol misuse (2025) and digital health applications for addiction treatment.